Antipodes Partners’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
Other funds holding SYK
GT
Antipodes Partners's SYK Position: Q2 2026 in Review
Antipodes Partners increased its Stryker (SYK) stake by 49% in Q2 2026, buying an estimated $56.4K and bringing the position to 541 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #97.
Antipodes Partners first reported a position in SYK in Q3 2025 and has held it in 4 quarters since. 2,267 funds tracked by Wall St. Rank hold SYK as of Q2 2026.
- Antipodes Partners held 541 shares of Stryker worth $170K as of Q2 2026.
- Antipodes Partners bought 179 Stryker shares in Q2 2026, an estimated $56.4K.
- Stryker made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #97 holding.
- Antipodes Partners first reported a position in Stryker in Q3 2025 and has held it in 4 quarters since.
- 2,267 funds tracked by Wall St. Rank held Stryker as of Q2 2026.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.